Implementation of a Serious Illness Conversation Program in a Health System: A Retrospective Observational Study
Listen to this summary
The authors aimed to evaluate the reach, timeliness, and quality of a Serious Illness Conversation Program (SICP) implemented in a health system, assessing factors influencing the completion of these conversations among eligible patients. Their findings revealed that nearly half of the eligible patients had documented serious illness conversations, with multiple sessions occurring for many, but highlighted a need for improved engagement, particularly for patients with dementia, and enhancements in conversation quality.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Journal of palliative medicine
View all →Jun 12, 2026 · Journal of palliative medicine
Clinical and Radiological Trajectories at the End of Life in Patients with Bone and Soft Tissue Sarcoma: A Retrospective Case Series
Jun 10, 2026 · Journal of palliative medicine
Integrating Artificial Intelligence-Based Simulation into Serious Illness Conversation Training: A Pilot Medical Student Intervention
Jun 8, 2026 · Journal of palliative medicine
Impact of the Life-Sustaining Treatment Decisions Act on End-of-Life Care in the Emergency Department
Jun 8, 2026 · Journal of palliative medicine
Outcomes for Hospitalized Patients with Comfort Measures Only Orders
Jun 4, 2026 · Journal of palliative medicine
Three-Week Monitoring After Anamorelin Initiation in Unresectable or Recurrent Pancreatic Cancer: Dietary Intake Category, Observed Body Weight, and Prognostic Nutritional Index
Jun 3, 2026 · Journal of palliative medicine
Early Palliative Care for People with Primary Malignant Brain Tumors: A Systematic Review
More in Internal Medicine
View all →Jun 25, 2026 · Blood
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
Jun 25, 2026 · Blood
Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate
Jun 25, 2026 · Blood
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms
Jun 25, 2026 · The American journal of sports medicine
Association of Central Acetabular Osteophytes With Microinstability and Increased Combined Anteversion in Borderline Dysplasia Hips
Jun 25, 2026 · Blood
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
